Araştırma Makalesi
BibTex RIS Kaynak Göster
Yıl 2022, Cilt: 39 Sayı: 2, 359 - 364, 18.03.2022

Öz

Kaynakça

  • 1. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798):265-269.
  • 2. Lupia T, Scabini S, Mornese Pinna S, Di Perri G, De Rosa FG, Corcione S. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist. 2020; 21:22-27.

Investigation of the clinical course of Covid-19 patients according to blood groups

Yıl 2022, Cilt: 39 Sayı: 2, 359 - 364, 18.03.2022

Öz

Objective: The aim of this study is to evaluate the effect of blood groups (BGs) on Covid-19 contraction and prognosis and to reveal the coefficients.
Methods: Patients who referred to Covid-19 outpatient clinics and had an established diagnosis of Covid-19 were included in the study. Their BGs, previous diagnoses and blood examination findings were retrospectively analyzed. Duration of hospitalization, clinical course and survival were recorded.
Results: The mean age of 365 subjects, 210 female and 155 male, was 45.5 years. Subjects with BG A developed Covid-19 at significantly higher rates (p = 0.001), while BG O was found associated with lower rates (p = 0.005). Lymphocyte count was found lower (p = 0.035) and rate of lung parenchymal involvement was higher (p = 0.003) in patients with Rh antigen. It was found that a higher percentage of patients with B BG required treatment in the intensive care unit (ICU) compared to other ABO BGs (p = 0.015).
Conclusion: These results suggest a higher risk of Covid-19 contraction in the population with BG A and lower risk for BG O population while indicating poorer prognosis for patients with BG B.

Kaynakça

  • 1. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798):265-269.
  • 2. Lupia T, Scabini S, Mornese Pinna S, Di Perri G, De Rosa FG, Corcione S. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist. 2020; 21:22-27.
Toplam 2 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Clinical Research
Yazarlar

Alper Ömeroğlu Bu kişi benim 0000-0002-7126-5538

Suleyman Ersoy 0000-0003-0001-9329

Emin Pala 0000-0001-9189-4342

Velittin Selçuk Engin 0000-0002-6338-4748

Erken Görünüm Tarihi 18 Mart 2022
Yayımlanma Tarihi 18 Mart 2022
Gönderilme Tarihi 30 Temmuz 2021
Kabul Tarihi 18 Ekim 2021
Yayımlandığı Sayı Yıl 2022 Cilt: 39 Sayı: 2

Kaynak Göster

APA Ömeroğlu, A., Ersoy, S., Pala, E., Engin, V. S. (2022). Investigation of the clinical course of Covid-19 patients according to blood groups. Journal of Experimental and Clinical Medicine, 39(2), 359-364.
AMA Ömeroğlu A, Ersoy S, Pala E, Engin VS. Investigation of the clinical course of Covid-19 patients according to blood groups. J. Exp. Clin. Med. Mart 2022;39(2):359-364.
Chicago Ömeroğlu, Alper, Suleyman Ersoy, Emin Pala, ve Velittin Selçuk Engin. “Investigation of the Clinical Course of Covid-19 Patients According to Blood Groups”. Journal of Experimental and Clinical Medicine 39, sy. 2 (Mart 2022): 359-64.
EndNote Ömeroğlu A, Ersoy S, Pala E, Engin VS (01 Mart 2022) Investigation of the clinical course of Covid-19 patients according to blood groups. Journal of Experimental and Clinical Medicine 39 2 359–364.
IEEE A. Ömeroğlu, S. Ersoy, E. Pala, ve V. S. Engin, “Investigation of the clinical course of Covid-19 patients according to blood groups”, J. Exp. Clin. Med., c. 39, sy. 2, ss. 359–364, 2022.
ISNAD Ömeroğlu, Alper vd. “Investigation of the Clinical Course of Covid-19 Patients According to Blood Groups”. Journal of Experimental and Clinical Medicine 39/2 (Mart 2022), 359-364.
JAMA Ömeroğlu A, Ersoy S, Pala E, Engin VS. Investigation of the clinical course of Covid-19 patients according to blood groups. J. Exp. Clin. Med. 2022;39:359–364.
MLA Ömeroğlu, Alper vd. “Investigation of the Clinical Course of Covid-19 Patients According to Blood Groups”. Journal of Experimental and Clinical Medicine, c. 39, sy. 2, 2022, ss. 359-64.
Vancouver Ömeroğlu A, Ersoy S, Pala E, Engin VS. Investigation of the clinical course of Covid-19 patients according to blood groups. J. Exp. Clin. Med. 2022;39(2):359-64.